TickerFactsScreenerDevelopers

Arbutus Biopharma Corp (ABUS) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2010: $12.41M2011: $9.03M2012: $47.02M2013: $68.72M2014: $72.19M2015: $166.78M2016: $23.41M2017: $54.29M2018: $36.94M2019: $31.80M2020: $52.25M2021: $109.28M2022: $30.78M2023: $26.29M2024: $36.33M2025: $18.01M$18.01M
2010Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$18.01M-50.4%
2024$36.33M+38.2%
2023$26.29M-14.6%
2022$30.78M-71.8%
2021$109.28M+109.1%
2020$52.25M+64.3%
2019$31.80M-13.9%
2018$36.94M-32.0%
2017$54.29M+131.9%
2016$23.41M-86.0%
2015$166.78M+131.0%
2014$72.19M+5.0%
2013$68.72M+46.1%
2012$47.02M+420.7%
2011$9.03M-27.2%
2010$12.41M—